Enzolytics, Inc. (ENZC)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
May 27, 2026, 12:20 PM EST
Enzolytics Market Cap
Enzolytics has a market cap or net worth of $3.38 million as of May 27, 2026. Its market cap has decreased by -17.65% in one year.
Market Cap
3.38M
Enterprise Value
n/a
Revenue
46.59K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 29, 2008, Enzolytics's market cap has decreased from 106.80M to 3.38M, a decrease of -96.83%. That is a compound annual growth rate of -17.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 3.38M | 133.33% |
| Dec 31, 2025 | 1.45M | -68.42% |
| Dec 31, 2024 | 4.59M | -91.73% |
| Dec 29, 2023 | 55.53M | -46.84% |
| Dec 30, 2022 | 104.44M | -45.90% |
| Dec 31, 2021 | 193.06M | -12.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eastgate Biotech | 3.17M |
| Iterum Therapeutics | 2.91M |
| LakeShore Biopharma | 2.88M |
| ProtoKinetix | 2.74M |
| Eloxx Pharmaceuticals | 2.73M |
| Vaccinex | 2.68M |
| Hepion Pharmaceuticals | 2.56M |
| VitaSpring Biomedical | 2.30M |